We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Erba-Transasia Group Acquires Turkish IVD Company

By LabMedica International staff writers
Posted on 23 Jan 2011
Erba Diagnostics Mannheim, GmbH (Erba), a German subsidiary of Transasia Biomedicals (Mumbai, India)--India's leading in vitro diagnostic (IVD) company--acquired a 100% stake in Diasis Diagnostic Systems (DDS; Istanbul, Turkey). More...


Erba Diagnostics Mannheim and Diasis Diagnostic Systems have drawn up growth plans based on achieving economies of scale, creating synergy through intragroup coordination, widening product offering, and strengthening its after-sales service support and distribution network.

With two other strategic acquisitions, PLIVA-Lachema Diagnostika (Brno, Czech Republic) in Europe and IVAX (Miami, FL, USA) in the United States, the Erba-Transasia Group will have a direct corporate presence in USA, Italy, Czech Republic, Russia, Germany, and India. The Group already has a presence in over 50 countries through its distribution and marketing network.

Diasis Diagnostic Systems, is involved in the development, production, and marketing of products for IVD in the fields of biochemistry, hematology and urine analysis. "We regard the acquisition by Erba as a great opportunity for Diasis Diagnostic Systems to aggressively promote the full range of Erba and DDS products in Turkey, Iran, Syria, Azerbaijan and the Turkish speaking Republics," said Ruchan Ozatay, director of DDS. The company has also established an export division, which exports its manufactured reagents to several countries including Greece, Bulgaria, Pakistan, India, Bangladesh, Korea etc.

Transasia Bio-Medicals Ltd. provides total solutions for clinical diagnosis in the field of biochemistry, hematology, immunology, critical care, coagulation, and urine analysis.

Related Links:

Erba Diagnostics Mannheim, GmbH
Transasia Biomedicals
Diasis Diagnostic Systems
PLIVA-Lachema Diagnostika
IVAX




New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Biochemical Analyzer
iBC 900
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.